Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Praxair (PX) Stock Forecast & Price Target

Praxair logo

PX Analyst Ratings Over Time

TypeCurrent Forecast
11/17/23 to 11/16/24
1 Month Ago
10/18/23 to 10/17/24
3 Months Ago
8/19/23 to 8/18/24
1 Year Ago
11/17/22 to 11/17/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
6 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.29$11.86$10.75$14.67
Forecasted Upside10.44% Upside5.44% Upside7.39% Upside59.77% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Buy

PX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Praxair Stock vs. The Competition

TypePraxairFinance CompaniesS&P 500
Consensus Rating Score
2.43
2.49
2.50
Consensus RatingHoldHoldModerate Buy
Predicted Upside10.44% Upside12.12% Upside9.86% Upside
News Sentiment Rating
Neutral News

See Recent PX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/12/2024JPMorgan Chase & Co.
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$11.00 ➝ $14.00+14.47%
11/11/2024Stephens
4 of 5 stars
 Boost TargetOverweight ➝ Overweight$12.00 ➝ $13.00+11.30%
11/11/2024Morgan Stanley
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$12.00 ➝ $13.00+11.30%
11/8/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform$12.50 ➝ $13.00+14.44%
10/22/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Beatty
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$10.50 ➝ $12.00+7.33%
10/16/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$13.00 ➝ $16.00+42.86%
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
10/7/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$11.00 ➝ $12.00+8.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:48 PM ET.


PX Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Praxair is $13.29, with a high forecast of $16.00 and a low forecast of $12.00.

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Praxair in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" PX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PX, but not buy additional shares or sell existing shares.

According to analysts, Praxair's stock has a predicted upside of 10.44% based on their 12-month stock forecasts.

Over the previous 90 days, Praxair's stock had 1 downgrade by analysts.

Praxair has been rated by research analysts at Barclays, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer, Stephens, and UBS Group in the past 90 days.

Analysts like Praxair less than other "finance" companies. The consensus rating score for Praxair is 2.43 while the average consensus rating score for "finance" companies is 2.49. Learn more on how PX compares to other companies.


This page (NYSE:PX) was last updated on 11/16/2024 by MarketBeat.com Staff
From Our Partners